DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Novo Nordisk (NYSE: NVO)

44.29 -0.06 (-0.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVO $44.29 -0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $44.50
Previous Close $44.35
Daily Range $44.09 - $44.56
52-Week Range $34.30 - $49.11
Market Cap $121.8B
P/E Ratio 0.00
Dividend (Yield) $0.61 (1.4%)
Ex-Dividend Date
Dividend Pay Date
03/21/14
04/02/14
Volume 680,508
Average Daily Volume 1,917,670
Current FY EPS $1.73

Sector

Healthcare

Industry

Drugs

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary Rss Feed

3 Dividend Stocks Better Than Pfizer, Inc.

Pfizer's sales and earnings are struggling, but results at Novartis, Amgen, and Novo Nordisk may mean they're better bets for dividend growth.

Sanofi: Recent Plunge Is A Buying Opportunity

Janssen Is Working Its Way Toward Anti-Obesity

PPH, GSK, NVO, SNY: Large Outflows Detected at ETF

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination

Pre-Market Activity Shows Heavy Volume And Movement For Novo Nordisk A/S (NVO)

Novo-Nordisk Is A Great Healthcare Stock That Isn't Overstretched

MannKind Is On The Mend

Dividend Contenders, Future Champions Or Future Failures: Part 6

Pre-Market Most Active for Nov 5, 2014 : SAN, FEYE, CRH, BABA, NVO, ALU, FB, TVIX, BAC, INTC, TRIP,

Pre-Market Most Active for Nov 5, 2014 : SAN, FEYE, CRH, BABA, NVO, ALU, FB, TVIX, BAC, INTC, TRIP, QQQ

Digesting Sanofi's Two Pieces Of News- Lantus' Challenging Outlook And The CEO Dismissal

See More NVO News...

NVO's Top Competitors

NVO $44.29 (-0.14%)
Current stock: NVO
JNJ $107.86 (0.35%)
Current stock: JNJ
NVS $94.98 (-0.30%)
Current stock: NVS
RHHBY $37.33 (-0.93%)
Current stock: RHHBY